Company / Net Income
Biofrontera Inc. Net Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$17.8M
FY2025
5-year range
-$37.7M / -$640.0K
FY2021-FY2025
Trend
+11.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 5 years, ranging from -$38M in FY2022 to -$640,000 in FY2023.
Based on SEC 10-K filings.
-$18M in FY2025.
Declined from -$640,000 to -$18M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 11.8% year-over-year.
- Peak net income was recorded in FY2023.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.8M | +11.8% |
| FY2024 | -$20.1M | -3045.5% |
| FY2023 | -$640.0K | +98.3% |
| FY2022 | -$37.7M | -243.3% |
| FY2021 | -$11.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026